Dupixent
- Product NDC
- 0024-5916
- 11-digit product format
- 000245916
- Labeler code
- 0024
- Product ID
- 0024-5916_ed234fa7-9084-4b79-ae02-66abe58043f3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dupilumab
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- sanofi-aventis U.S. LLC
- Application
- BLA761055
- Marketing category
- BLA
- Marketing start
- 2017-03-28
- Marketing end
- 0000-00-00
- Substance
- DUPILUMAB
- Active strength
- 300 mg/2mL
- Pharmacologic classes
- Interleukin-4 Receptor alpha Antagonist [EPC],Interleukin 4 Receptor alpha Antagonists [MoA],Antibodies, Monoclonal [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0024-5916-01 | 00024591601 | 2 SYRINGE, GLASS in 1 CARTON (0024-5916-01) > 2 mL in 1 SYRINGE, GLASS | 2017-03-28 | 0000-00-00 | No | No | Current |